- Home
- ALL vs HLN Comparison
ALL vs HLN Comparison
Compare ALL & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALL
- HLN
- Stock Information
- Founded
- ALL 1931
- HLN 2022
- Country
- ALL United States
- HLN United Kingdom
- Employees
- ALL N/A
- HLN N/A
- Industry
- ALL Property-Casualty Insurers
- HLN Package Goods/Cosmetics
- Sector
- ALL Finance
- HLN Consumer Discretionary
- Exchange
- ALL Nasdaq
- HLN Nasdaq
- Market Cap
- ALL 49.6B
- HLN 45.6B
- IPO Year
- ALL 1993
- HLN N/A
- Fundamental
- Price
- ALL $202.64
- HLN $10.74
- Analyst Decision
- ALL Strong Buy
- HLN Buy
- Analyst Count
- ALL 15
- HLN 1
- Target Price
- ALL $223.20
- HLN $10.95
- AVG Volume (30 Days)
- ALL 1.5M
- HLN 15.0M
- Earning Date
- ALL 04-30-2025
- HLN 02-27-2025
- Dividend Yield
- ALL 1.97%
- HLN 1.56%
- EPS Growth
- ALL 216.18
- HLN 38.94
- EPS
- ALL 14.64
- HLN 0.20
- Revenue
- ALL $65,299,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- ALL N/A
- HLN $4.78
- Revenue Next Year
- ALL $8.13
- HLN $4.75
- P/E Ratio
- ALL $13.84
- HLN $27.01
- Revenue Growth
- ALL 11.49
- HLN N/A
- 52 Week Low
- ALL $156.66
- HLN $8.12
- 52 Week High
- ALL $212.91
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- ALL 57.54
- HLN 60.96
- Support Level
- ALL $192.52
- HLN $10.57
- Resistance Level
- ALL $206.11
- HLN $10.85
- Average True Range (ATR)
- ALL 3.82
- HLN 0.14
- MACD
- ALL 1.10
- HLN 0.05
- Stochastic Oscillator
- ALL 79.78
- HLN 87.21
About ALL Allstate Corporation (The)
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.